[PRLD] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ-
YoY-
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -16,760 -11,408 -9,511 -10,039 -6,734 -5,399 -5,399 112.36%
Tax 0 0 0 0 0 0 0 -
NP -16,760 -11,408 -9,511 -10,039 -6,734 -5,399 -5,399 112.36%
Tax Rate - - - - - - - -
Total Cost 16,760 11,408 9,511 10,039 6,734 5,399 5,399 112.36%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.44 -0.30 -0.29 -0.31 -0.21 -3.43 -3.43 -74.46%
EPS Diluted -0.44 -0.30 -0.29 -0.31 -0.21 -3.42 -3.42 -74.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.